Charles Ruetsch, Ph.D.
President & CEO
As founder, President, and CEO of Health Analytics, Charles Ruetsch, Ph.D., draws on nearly 20 years of experience in managed care and post-market pharmaceutical outcomes research and management. Dr. Ruetsch’s diverse background enables him to balance innovative, sound health care science with cutting edge business strategies that maximize quality, efficiency and profitability for 3rd party payors, manufacturer and large provider clients.
Sensitive to the evolving demands of a changing health care market, Dr. Ruetsch is a practical executive with a rare combination of business savvy and scientific expertise. The depth and breadth of his combined experience has shaped his fundamental belief that health care research must have a measurable impact on business operations.
Prior to forming Health Analytics, Dr. Ruetsch held several senior level positions in functional areas such as: 1) outcomes research, 2) health improvement intervention development, and 3) health care program evaluation for Fortune 1000 managed care and pharmacy benefit management companies. While Dr. Ruetsch provides visionary leadership for Health Analytics, he also lends his expertise to client projects, applying his knowledge of behavior-change technologies, program evaluation, study design, statistical analysis and the strategic application of research findings to address client issues.
Dr. Ruetsch’s results-oriented approach has led him to create provider and consumer health educational interventions including tools to improve treatment compliance. His work in disease management includes an emphasis on influencing provider and patient behavior to improve clinical outcomes. Dr. Ruetsch has developed several physician Continuing Medical Education courses in diverse diseases areas that incorporate sophisticated educational technologies. His diverse experience has proven invaluable to achieving client objectives.
Previously, Dr. Ruetsch held several progressively responsible positions in quality improvement and outcomes, culminating in the position of Vice President QI and Outcomes for Magellan Behavioral Health, an international managed behavioral health company. He also served as director of clinical product development and outcomes for CVS Caremark (formerly AdvancePCS, and director of health improvement programs and health outcomes research scientist for MEDTAP international. Earlier in his career, Dr. Ruetsch was director of data analysis for a mental health outcomes tracking firm and held several other related positions in data analysis and outcomes management. Dr. Ruetsch began his career as a research statistician for a private psychiatric hospital.